ESC 365 - Impact of medical PAH therapy on outcomes in ACHD

Open Access

Impact of medical PAH therapy on outcomes in ACHD

Session: Pulmonary arterial hypertension associated with CHD

Topic: Adult Congenital Heart Disease (ACHD)

Speaker: Professor G. Diller (Muenster, DE)

Event: EuroACHD 2023

Seminar Presentation

Add to my library

About the speaker

Professor Gerhard Paul Diller

University Hospital Munster - UKM, Muenster (Germany)

14 presentations

1 follower

4 more presentations in this session

Mechanistic insight of right ventricle dysfunction in PAH-role of right ventricle strain in CHD

Speaker: Professor P. Moceri (Nice, FR)

Heart and lung transplantation in PAH-CHD

Speaker: Mr S. Hascoet (Le Plessis Robinson, FR)

Treat and repair strategy

Speaker: Professor K. Dimopoulos (London, GB)

Discussion

Access the full session

Pulmonary arterial hypertension associated with CHD

Speakers: Professor G. Diller, Professor P. Moceri, Mr S. Hascoet, Professor K. Dimopoulos

About the event

EuroACHD 2023

21 April - 22 April 2023

Seminar

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources